Literature DB >> 20647408

Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

Julia A Newton-Bishop1, Yu-Mei Chang, Mark M Iles, John C Taylor, Bert Bakker, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes, Elaine Fitzgibbon, Faye Elliott, Peter A Kanetsky, Mark Harland, Jennifer H Barrett, D Timothy Bishop.   

Abstract

BACKGROUND: Increased number of melanocytic nevi is a potent melanoma risk factor. We have carried out a large population-based case-control study to explore the environmental and genetic determinants of nevi and the relationship with melanoma risk.
METHODS: We report nevus phenotype in relation to differing patterns of sun exposure, inherited variation at loci shown in recent genome-wide association studies to be nevus genes, and risk.
RESULTS: Increased numbers of nevi were associated with holiday sun exposure, particularly on intermittently sun-exposed body sites (test for P(trend) < 0.0001). Large nevi were also associated with holiday sun exposure (P = 0.002). Single nucleotide polymorphisms (SNP) on chromosomes 9 and 22 were associated with increased numbers of nevi (P = 0.04 and P = 0.002 respectively) and larger nevi (P = 0.03 and P = 0.002), whereas that on chromosome 6 was associated only with large nevi (P = 0.01). Melanoma risk was associated with increased nevus count, large nevi, and atypical nevi for tumors in all body sites (including rare sites) irrespective of age. The risk persisted when adjusted for inheritance of nevus SNPs.
CONCLUSIONS: The at-risk nevus phenotype is associated with behaviors known to increase melanoma risk (holiday sun exposure). Although SNPs on chromosomes 6, 9, and 22 were shown to be nevus genes, they explained only a small proportion of melanoma risk and nevus phenotype; therefore, several nevus genes likely remain to be identified. IMPACT: This article confirms the importance of nevi in melanoma pathogenesis and increases understanding of their genetic determinants. (c)2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20647408      PMCID: PMC2923062          DOI: 10.1158/1055-9965.EPI-10-0233

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

1.  Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.

Authors:  V Bataille; H Snieder; A J MacGregor; P Sasieni; T D Spector
Journal:  J Natl Cancer Inst       Date:  2000-03-15       Impact factor: 13.506

2.  Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study.

Authors:  R C Wachsmuth; R M Gaut; J H Barrett; C L Saunders; J A Randerson-Moor; A Eldridge; N G Martin; T D Bishop ; J A Newton Bishop
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

3.  The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren.

Authors:  Paolo Carli; Luigi Naldi; Silvia Lovati; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2002-10-01       Impact factor: 7.396

4.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

5.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.

Authors:  David C Whiteman; Peter Watt; David M Purdie; Maria Celia Hughes; Nicholas K Hayward; Adèle C Green
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

6.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

Review 7.  Skin colour and skin cancer - MC1R, the genetic link.

Authors:  R A Sturm
Journal:  Melanoma Res       Date:  2002-10       Impact factor: 3.599

8.  NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Authors:  Katarina Omholt; Anton Platz; Lena Kanter; Ulrik Ringborg; Johan Hansson
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

9.  Sun exposure and number of nevi in 5- to 6-year-old European children.

Authors:  Madeleine Dulon; Michael Weichenthal; Maria Blettner; Marianne Breitbart; Melanie Hetzer; Rüdiger Greinert; Cornelia Baumgardt-Elms; Eckard W Breitbart
Journal:  J Clin Epidemiol       Date:  2002-11       Impact factor: 6.437

10.  Genetic susceptibility to naevi--a twin study.

Authors:  D F Easton; G M Cox; A M Macdonald; B A Ponder
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  39 in total

1.  Risk Factors of Subsequent Primary Melanomas in Austria.

Authors:  Christoph Müller; Judith Wendt; Sabine Rauscher; Raute Sunder-Plassmann; Erika Richtig; Ingrid Fae; Gottfried Fischer; Ichiro Okamoto
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

2.  Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.

Authors:  Hongliang Liu; Li-E Wang; Zhensheng Liu; Wei V Chen; Christopher I Amos; Jeffrey E Lee; Mark M Iles; Matthew H Law; Jennifer H Barrett; Grant W Montgomery; John C Taylor; Stuart MacGregor; Anne E Cust; Julia A Newton Bishop; Nicholas K Hayward; D Timothy Bishop; Graham J Mann; Paul Affleck; Qingyi Wei
Journal:  Carcinogenesis       Date:  2013-01-04       Impact factor: 4.944

Review 3.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

Review 4.  Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Authors:  Jennifer M Huang; Ijeuru Chikeka; Thomas J Hornyak
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 5.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

6.  Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Authors:  Marina Kvaskoff; David C Whiteman; Zhen Z Zhao; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward; David L Duffy
Journal:  Twin Res Hum Genet       Date:  2011-10       Impact factor: 1.587

7.  Cutaneous nevi and risk of melanoma death in women and men: A prospective study.

Authors:  Wen-Qing Li; Eunyoung Cho; Martin A Weinstock; Suyun Li; Meir J Stampfer; Abrar A Qureshi
Journal:  J Am Acad Dermatol       Date:  2019-01-11       Impact factor: 11.527

8.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

9.  A variant in FTO shows association with melanoma risk not due to BMI.

Authors:  Mark M Iles; Matthew H Law; Simon N Stacey; Jiali Han; Shenying Fang; Ruth Pfeiffer; Mark Harland; Stuart Macgregor; John C Taylor; Katja K Aben; Lars A Akslen; Marie-Françoise Avril; Esther Azizi; Bert Bakker; Kristrun R Benediktsdottir; Wilma Bergman; Giovanna Bianchi Scarrà; Kevin M Brown; Donato Calista; Valérie Chaudru; Maria Concetta Fargnoli; Anne E Cust; Florence Demenais; Anne C de Waal; Tadeusz Dębniak; David E Elder; Eitan Friedman; Pilar Galan; Paola Ghiorzo; Elizabeth M Gillanders; Alisa M Goldstein; Nelleke A Gruis; Johan Hansson; Per Helsing; Marko Hočevar; Veronica Höiom; John L Hopper; Christian Ingvar; Marjolein Janssen; Mark A Jenkins; Peter A Kanetsky; Lambertus A Kiemeney; Julie Lang; G Mark Lathrop; Sancy Leachman; Jeffrey E Lee; Jan Lubiński; Rona M Mackie; Graham J Mann; Nicholas G Martin; Jose I Mayordomo; Anders Molven; Suzanne Mulder; Eduardo Nagore; Srdjan Novaković; Ichiro Okamoto; Jon H Olafsson; Håkan Olsson; Hubert Pehamberger; Ketty Peris; Maria Pilar Grasa; Dolores Planelles; Susana Puig; Joan Anton Puig-Butille; Juliette Randerson-Moor; Celia Requena; Licia Rivoltini; Monica Rodolfo; Mario Santinami; Bardur Sigurgeirsson; Helen Snowden; Fengju Song; Patrick Sulem; Kristin Thorisdottir; Rainer Tuominen; Patricia Van Belle; Nienke van der Stoep; Michelle M van Rossum; Qingyi Wei; Judith Wendt; Diana Zelenika; Mingfeng Zhang; Maria Teresa Landi; Gudmar Thorleifsson; D Timothy Bishop; Christopher I Amos; Nicholas K Hayward; Kari Stefansson; Julia A Newton Bishop; Jennifer H Barrett
Journal:  Nat Genet       Date:  2013-03-03       Impact factor: 38.330

10.  Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resorts.

Authors:  David B Buller; Peter A Andersen; Barbara J Walkosz; Michael D Scott; Larry Beck; Gary R Cutter
Journal:  Prev Med       Date:  2017-02-09       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.